ISTH offers a wide variety of ways to be involved in the ISTH 2025 Congress, including through:

• Symposia

• Presentation theaters

• Exhibition booths

• Official Congress publications

• Educational and scientific activities

• Networking and attendee services

• Industry meeting and networking facilities

• Advertising, branding and/or other sponsorship opportunities
   

As a supporter, you will be able to:

• Present your products, services, solutions as well as scientific breakthroughs to the largest and most influential group of thrombosis and hemostasis experts and decision makers in the world

• Elevate your company’s visibility and increase its brand awareness

• Engage and interact with over 6,500 decision makers and thought leaders in basic science, laboratory and clinical practice from around the world

• Further your network by engaging with the next generation of key opinion leaders in thrombosis and hemostasis

• Create meaningful partnerships and awareness about your products, services and solutions

• Learn about the challenges as well as proposed approaches to today’s pressing scientific, diagnostic and clinical problems

• Actively discuss how to translate the latest scientific breakthroughs into clinical evaluation and therapeutic approaches

• Participate in a physical and virtual meeting environment conducive to scientific exchange and dialogue about the latest products and services available to our professional community

• Partner with the leading international Society in the field of thrombosis and hemostasis, responsible for the major advancements in our field for over 50 years

• Support the mission of the ISTH to advance the understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders

​

We recognize the important role of our corporate partners play as participating and contributing stakeholders, and as such we welcome ideas on novel sponsorship opportunities and development of packages to meet partner’s needs.

​

Who should support or exhibit at ISTH 2025?

• Pharmaceutical and biopharmaceutical companies with therapies (approved or in development) targeted at

  • thrombosis (venous and arterial)

  • hemophilia and other inherited or acquired bleeding disorders

  • benign hematological disorders

• Diagnostic, service and solutions companies (laboratory equipment, molecular diagnostics (NGS-based genetic profiling, clinical interpretation of genomic data), reagents and point-of-care devices) relevant to the thrombosis, hemostasis/hematology laboratory and clinical practice

• Clinical research organizations

• Medical education companies

• Publishers

• Other corporations, not-for-profit organizations, professional societies and other organizations involved in or with an interest to reach physicians and researchers in the fields of thrombosis, hemostasis and wider benign hematology

 

Innovations and features at ISTH 2025

In an effort to innovate but also to proactively address changes in the regulatory and CME environment, ISTH carefully listens to its industry partners, reviews latest guidance and pays attention to best practices. Our main intentions are to create a solid return-on-objectives and create solid return-on-investment for all stakeholders involved in ISTH 2025, including our industry partners.

 

We are pleased to highlight the following features at ISTH 2025:

• No competing time slots between dedicated industry exhibition and industry symposia

• Exhibit opening hours with an intensified program encouraging attendees to spend time in the exhibition halls

• Presentation (former “Product”) Theaters

• Corporate (Hospitality) Suites

• Other industry meeting and networking rooms

• A variety of true-and-tested as well as new conference and delegate services to positively shape and assist the delegate experience

• An exhibit and sponsorship support system for our industry partners

• And many more…

​

For more information and/or to express your interest in the Congress, please contact: Kelsea Nolan, Exhibition and Sponsorship Sales Manager, at Kelsea_Nolan@isth.org.